Stock Price
0.51
Daily Change
-0.01 -0.98%
Monthly
31.17%
Yearly
426.04%
Q2 Forecast
0.49

Starpharma Holdings reported AUD10.83M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 51.34M 38.14M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025